clinical operations
Study start-up pulse report
July 24 by Pharma IQ
Veeva 2020 Study Start-up Pulse Report reveals that 81 per cent of survey respondents use spreadsheets to manage study start-up processes
Developing Clinical Trials for Oncology Part 3: Growth Trends in Oncology Therapeutics
September 22 by Pharmaceuticals & Biotechnology EditorMore than ever clinical trials are more complicated and more difficult to run. Denis Mir, Senior Manager of Clinical Operations in Oncology at Eisai Global Clinical Development, shares his though...
Developing Clinical Trials for Oncology Part 4: The Recipe for Success
September 22 by Pharmaceuticals & Biotechnology EditorBiotechs have fuelled the oncology therapeutic area with many sucessful drugs. Denis Mir, Senior Manager of Clinical Operations in Oncology at Eisai Global Clinical Development, shares his though...
Developing Clinical Trials for Oncology Part 2: Outsourcing and Strategic Alliances
September 22 by Pharmaceuticals & Biotechnology Editor[inlinead] Denis Mir, Senior Manager of Clinical Operations in Oncology at Eisai Global Clinical Development, shares his thoughts on outsourcing and strategic alliances in clinical trial...
Cutting Attrition Rates in Your CNS Clinical Trials
January 07 by Helen WinsorDr. Wolfgang Eglmeier, Head of Clinical Operations Germany, Grünenthal GmbH, joins Helen Winsor from Pharma IQ, to discuss optimising clinical development in CNS. He outlines the main challenges when...
Developing Clinical Trials for Oncology - Denis Mir, Eisai Global Clinical Development
May 21 by Pharmaceuticals & Biotechnology Editor[inlinetext]
Genzyme China: 3 Top Tips for Effective Clinical Operations
April 19 by Wang TaoWith more clinical trials being held in China than ever before, clinical trial supply systems need to become increasingly sophisticated in order to cope with local regulations, importation and exporta...
